Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.
buy Belinostat | Belinostat supplier | purchase Belinostat | Belinostat cost | Belinostat manufacturer | order Belinostat | Belinostat distributor
Keywords: PXD 101; PXD101; PXD-101; PX105684; PX-105684; PX 105684; NSC726630